Onward Medical N.V. (EBR:ONWD)
3.100
+0.100 (3.33%)
Apr 10, 2026, 5:37 PM CET
Onward Medical Employees
Onward Medical had 103 employees as of December 31, 2024. The number of employees increased by 3 or 3.38% compared to the previous year.
Employees
103
Change (1Y)
3
Growth (1Y)
3.38%
Revenue / Employee
€52,563
Profits / Employee
€405,699
Market Cap
173.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103 | 3 | 3.38% |
| Dec 31, 2023 | 99 | 3 | 3.23% |
| Dec 31, 2022 | 96 | 19 | 24.97% |
| Dec 31, 2021 | 77 | 22 | 39.82% |
| Dec 31, 2020 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| argenx SE | 1,863 |
| European Medical Solutions | 123 |
| Hyloris Pharmaceuticals | 50 |
| Celyad Oncology | 19 |
| Oxurion NV | 11 |
| BioSenic | 7 |
Onward Medical News
- 11 days ago - ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions - GlobeNewsWire
- 11 days ago - Onward Medical NV (ONWRF) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 11 days ago - Full Year 2025 ONWARD Medical NV Earnings Call & Business Update Transcript - GuruFocus
- 12 days ago - ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones - GlobeNewsWire
- 20 days ago - ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update - GlobeNewsWire
- 2 months ago - ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury - GlobeNewsWire
- 2 months ago - ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement - GlobeNewsWire
- 4 months ago - ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 - GlobeNewsWire